• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Cumulative percent of contracts awarded over the micro-purchase threshold which are competed within the month (1)

Dictionary: The Competition in Contracting Act of 1984, encourages competition for the award of all types of government contracts to increase the number of competitors and to increase the saving through lower, more competitive pricing. Further, President Obama has mandated that the Federal government save $40B a year in contracting and one way to achieve this savings is through competing contract actions.

The Department has mandated that at least 65% of all contract actions awarded over the micro-purchase threshold are competed.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetPercent
Oct – Dec 20106587
Jan – Mar 20116592.9
Apr – Jun 20116590.1
Jul – Sep 20116592.7

Footnotes

  • (1) $3K and under is a micro purchase and is not subject to competition rules.

Cumulative number of contracts over the micro-purchase threshold competed within the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct – Dec 2010N/A202
Jan – Mar 2011N/A262
Apr – Jun 2011N/A398
Jul – Sep 2011N/A1,735

FY 2011 Year-End Total: 1,735

Cumulative number of contracts over the micro-purchase threshold awarded within the month (2)

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct – Dec 2010N/A263
Jan – Mar 2011N/A343
Apr – Jun 2011N/A542
Jul – Sep 2011N/A2,122

FY 2011 Year-End Total: 2,122

Footnotes

  • (2) Amount (actions and dollars) also includes awards that aren’t available for competition for actions that are exempt by statute from competition.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.